Letter to the Editor: Serum bioavailable 25‐hydroxyvitamin D levels correlate with hepatocellular carcinoma survival
Lu‐Lu Zhai, Shi‐Hui Zhen, Zhi‐Gang Tang – 17 September 2021
Distal Gastroduodenal Arterial Inflow as a Salvage Strategy for Extensive Intraoperative Arterial Dissectıon in Living Donor Liver Transplantation
Sezai Yilmaz, Sami Akbulut, Sertac Usta, Cemalettin Koc, Koray Kutluturk – 17 September 2021
Protecting Patients With Cirrhosis From Coronavirus Disease 2019: Identifying Gaps in Vaccination Rates
David S. Goldberg, Cameron R. Wolfe, Robert S. Brown, Elizabeth C. Verna – 17 September 2021
Recent Improvement in Survival Outcomes and Reappraisal of Prognostic Factors in Pediatric Living Donor Liver Transplantation
Seak Hee Oh, In Sook Jeong, Dae Yeon Kim, Jung‐Man Namgoong, Won Kyoung Jhang, Seong Jong Park, Dong‐Hwan Jung, Deok Bog Moon, Gi‐Won Song, Gil‐Chun Park, Tae‐Yong Ha, Chul‐Soo Ahn, Ki‐Hun Kim, Shin Hwang, Sung Gyu Lee, Kyung Mo Kim – 17 September 2021 – Living donor liver transplantation (LDLT) is a significant advancement for the treatment of children with end‐stage liver disease given the shortage of deceased donors. The ultimate goal of pediatric LDLT is to achieve complete donor safety and zero recipient mortality.
Reply
Abu Bakar Hafeez Bhatti, Nusrat Yar Khan – 17 September 2021
Cardiac Risk Assessment in Liver Transplant Candidates: A Survey of National Practice Patterns
Pranab M. Barman, Ryan M. Chadha, Lisa B. VanWagner – 17 September 2021
Reply
Ai‐Ping Fang, Yao‐Jun Zhang, Min‐Shan Chen, Hui‐Lian Zhu – 17 September 2021
Macroscopic Characteristics of the Native Liver in Children With MPV17‐Related Mitochondrial DNA Depletion Syndrome: An Indication for Performing Liver Transplantation?
Mureo Kasahara, Seisuke Sakamoto, Akinari Fukuda, Reiko Horikawa, Reiko Ito, Hajime Uchida, Yusuke Yanagi, Seiichi Shimizu, Toshimasa Nakao, Kotaro Mimori, Chizuko Haga, Andrea Schlegel, Akira Ohtake, Masaru Shimura, Takuya Fushimi, Keiko Ichimoto, Ayako Matsunaga, Kei Murayama – 17 September 2021
Genome‐Wide Association Study of NAFLD Using Electronic Health Records
Cameron J. Fairfield, Thomas M. Drake, Riinu Pius, Andrew D. Bretherick, Archie Campbell, David W. Clark, Jonathan A. Fallowfield, Caroline Hayward, Neil C. Henderson, Peter K. Joshi, Nicholas L. Mills, David J. Porteous, Prakash Ramachandran, Robert K. Semple, Catherine A. Shaw, Cathie L.M. Sudlow, Paul R.H.J. Timmers, James F. Wilson, Stephen J. Wigmore, Ewen M. Harrison, Athina Spiliopoulou – 16 September 2021 – Genome‐wide association studies (GWAS) have identified several risk loci for nonalcoholic fatty liver disease (NAFLD).
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
Nia Adeniji, Renumathy Dhanasekaran – 16 September 2021 – Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related mortality worldwide. Early detection of HCC enables patients to avail curative therapies that can improve patient survival. Current international guidelines advocate for the enrollment of patients at high risk for HCC, like those with cirrhosis, in surveillance programs that perform ultrasound every 6 months.